Faeth Therapeutics, Inc. (FTH)
28.00
-1.05
(-3.61%)
USD |
NASDAQ |
Sep 25, 16:00
27.75
-0.25
(-0.89%)
Pre-Market: 19:59
Faeth Therapeutics EPS Diluted (Quarterly) : -2.836 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.836 |
| March 31, 2026 | -131.45 |
| December 31, 2025 | -3.739 |
| September 30, 2025 | -3.622 |
| June 30, 2025 | -3.915 |
| March 31, 2025 | -0.2725 |
| December 31, 2024 | -6.175 |
| September 30, 2024 | -0.2884 |
| June 30, 2024 | -0.2845 |
| March 31, 2024 | -0.319 |
| December 31, 2023 | -0.2962 |
| September 30, 2023 | -0.2792 |
| June 30, 2023 | -0.3077 |
| March 31, 2023 | -0.3297 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.3979 |
| September 30, 2022 | -0.4367 |
| June 30, 2022 | -0.3431 |
| March 31, 2022 | -0.4048 |
| December 31, 2021 | -0.306 |
| September 30, 2021 | -0.3166 |
| June 30, 2021 | -0.3194 |
| March 31, 2021 | -0.2606 |
| December 31, 2020 | -0.1677 |
| September 30, 2020 | -0.1755 |
| June 30, 2020 | -0.1605 |
| March 31, 2020 | -0.1568 |
| December 31, 2019 | -0.2611 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Opus Genetics, Inc. | -0.139 |
| Perspective Therapeutics, Inc. | -0.222 |
| Praxis Precision Medicines, Inc. | -2.874 |
| Nuvectis Pharma, Inc. | -0.299 |
| Jade Biosciences, Inc. | -0.7569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.01M |
| Total Expenses (Quarterly) | 16.01M |
| Enterprise Value | 544.24M |
| Earnings Yield | -505.9% |
| Normalized Earnings Yield | -232.43 |